Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study

NCT03919253 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

COMBINATION_PRODUCT: pyrotinib maleate tablets+nab-paclitaxel

Sponsor

Hebei Medical University Fourth Hospital